Twice-Yearly Lenacapavir or Daily F/TAF for HIV Prevention in Cisgender WomenLinda‐Gail Bekker, Flavia Matovu Kiweewa, Moupali Das et al.|New England Journal of Medicine|2024Cited by 471
High Asymptomatic Carriage With the Omicron Variant in South AfricaNigel Garrett, Sufia Dadabhai, Maurine D. Miner et al.|Clinical Infectious Diseases|2022Cited by 81
Hybrid versus vaccine immunity of mRNA-1273 among people living with HIV in East and Southern Africa: a prospective cohort analysis from the multicentre CoVPN 3008 (Ubuntu) studyNigel Garrett, Moelo Malahleha, Asa Tapley et al.|EClinicalMedicine|2025Cited by 5
Hybrid Versus Vaccine Immunity of mRNA-1273 Among People Living with HIV in East and Southern Africa: The Multicentre, Open-Label COVPN 3008 (Ubuntu) Clinical TrialNigel Garrett, Moelo Malahleha, Asa Tapley et al.|SSRN Electronic Journal|2024Cited by 0
Hybrid versus vaccine immunity of mRNA-1273 among people living with HIV in East and Southern Africa: a prospective cohort analysis from the multicentre CoVPN 3008 (Ubuntu) studySufia Dadabhai, Jia Jin Kee, Mubiana Inambao et al.|UNC Libraries|2025Cited by 0